Cases filed in Delaware
Cases 71 - 80 of 105
Otsuka Pharmaceutical Co. Ltd. v. Par Pharmaceutical Inc.
as 1:2013cv01979
Plaintiff: Otsuka Pharmaceutical Co. Ltd.
Defendant: Par Pharmaceutical Inc.
Counter_claimant: Par Pharmaceutical Inc.
Counter_defendant: Otsuka Pharmaceutical Co. Ltd.
Cause Of Action: 35 U.S.C. § 271
Forest Laboratories Inc. et al v. Par Pharmaceutical Inc.
as 1:2013cv01606
Plaintiff: Forest Laboratories Inc. , Forest Laboratories Holdings Ltd. and Royalty Pharma Collection Trust
Defendant: Par Pharmaceutical Inc.
Counter_claimant: Par Pharmaceutical Inc.
Counter_defendant: Forest Laboratories Holdings Ltd. , Forest Laboratories Inc. and Royalty Pharma Collection Trust
Cause Of Action: 35 U.S.C. § 271
Takeda Pharmaceuticals USA Inc. v. Par Pharmaceutical Companies Inc. et al We have downloadable decisions or orders for this case
as 1:2013cv01524
Plaintiff: Takeda Pharmaceuticals USA Inc.
Defendant: Par Pharmaceutical Companies Inc. and Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Par Pharmaceutical Inc.
as 1:2013cv01467
Plaintiff: Novartis Pharmaceuticals Corporation , Novartis AG , Novartis Pharma AG and others
Defendant: Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Reckitt Benckiser Pharmaceuticals Inc. et al v. Par Pharmaceutical Inc. et al
as 1:2013cv01461
Plaintiff: Reckitt Benckiser Pharmaceuticals Inc. , RB Pharmaceuticals Limited and MonoSol Rx LLC
Defendant: Par Pharmaceutical Inc. , IntelGenX Technologies Corp. and LTS Lohmann Therapy Systems Corp.
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical Inc. et al v Breckenridge Pharmaceutical Inc.
as 1:2013cv01114
Plaintiff: Par Pharmaceutical Inc. and Alkermes Pharma Ireland Limited
Defendant: Breckenridge Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Alza Corporation et al v. Par Pharmaceutical Inc. et al We have downloadable decisions or orders for this case
as 1:2013cv01104
Plaintiff: Alza Corporation and Janssen Pharmaceuticals Inc.
Defendant: Par Pharmaceutical Inc. , Actavis Elizabeth LLC and Actavis Inc.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Bayer Pharma AG et al v. Par Pharmaceutical Inc. et al
as 1:2013cv00845
Plaintiff: Bayer Pharma AG , Bayer Intellectual Property GMBH and Bayer HealthCare Pharmaceuticals Inc.
Defendant: Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Sucampo AG et al v. Anchen Pharmaceuticals Inc. et al
as 1:2013cv00202
Plaintiff: Sucampo AG , Sucampo Pharmaceuticals Inc. , R-Tech Ueno Ltd. and others
Defendant: Anchen Pharmaceuticals Inc. , Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Horizon Pharma Inc. et al v. Par Pharmaceutical Companies, Inc. et al
as 1:2013cv00102
Plaintiff: Horizon Pharma Inc. and Horizon Pharma USA Inc.
Defendant: Par Pharmaceutical Companies, Inc. and Par Pharmaceutical Inc.
Counter_claimant: Par Pharmaceutical Inc. and Par Pharmaceutical Companies, Inc.
Counter_defendant: Horizon Pharma USA Inc. and Horizon Pharma Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?